Viðskipti · 14.11.20261 min read
CARsgen's CAR-T Product Satri-cel Included in China's Commercial Health Insurance Innovative Drug List
Staðbundin vélþýðing · Upprunalegt tungumál heimildar
Summary
SHANGHAI, Nov. 14, 2026 — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that satricabtagene autoleucel…
Upprunalegt tungumál heimildar: PR Newswire — Global News ReleasesOpna upprunalega tilkynningu →